Atrial electromechanical coupling interval as a possible predictive factor for heart failure in a distant future

2008 ◽  
Vol 7 ◽  
pp. 46-47
Author(s):  
J CLAESSENS ◽  
P CLAESSENS ◽  
C CLAESSENS ◽  
M CLAESSENS ◽  
M CLAESSENS
2008 ◽  
Vol 14 (6) ◽  
pp. S60-S61
Author(s):  
Philip P.M. Claessens ◽  
Christophe C.W. Claessens ◽  
Marc M.M. Claessens ◽  
Maria C.F. Claessens ◽  
Jan E.J. Claessens

2020 ◽  
Vol 6 (1) ◽  
pp. 34-40
Author(s):  
Rosa Syafitri ◽  
Pintoko Tedjokusumo ◽  
M. Rizki Akbar

Background: Chronic Heart Failure (CHF) can lead to atrial and structural remodeling that result in non-homogenous impulse propagation and inter and intra-atrial conduction delay. Prolongation of interval of Atrial ElectroMechanical Coupling (AEMC) in CHF patient was related to atrial electromechanical remodeling and Atrial Fibrillation (AF) risk. Hyperuricemia found in CHF played a role in the pathophysiology of AF through neuro-hormonal activation, oxidative stress, inflammation and ionic channel dysfunction. This study aimed to investigate the association between uric acid and AEMCinterval in CHF with reduced ejection fraction.Methods: This study was a cross sectional study. Subject were CHF patients with reduced ejection fraction and sinus rhythm who visited cardiology clinic Dr. Hasan Sadikin Bandung between July - September 2018. Blood sampling for uric acid was performed in the morning after fasting 10-12 hours. AEMC interval was measured by echocardiography Tissue Doppler Imaging (TDI) as time interval from onset of P wave in surface electrocardiography to onset of A wave from TDI in lateral atrial wall called lateral PA interval. Statistical analysis was done by linear regression analysis to control confounding variables.Results: This study involved 51 CHF patients with reduced ejection fraction (< 40%) with median age 62 (27 – 81) year, 92% have history of myocardial infarction or coronary revascularization, 16% have diabetes mellitus, 51% have hypertension, and eGFR of 60.9 + 22.1. Mean uric acid was 8.0 + 2.2 mg/dL and mean lateral PA interval was 67.4 + 19.2 ms. Uric acid was significantly associated with lateral PA interval (R : 0.665, adjusted R2 0.407, P < 0.001) after controlling the confounding variables: systolic blood pressure and diastolic function.Conclusion: Uric acid significantly correlated positively with AEMC interval in CHF patients with reduced ejection fraction.


2021 ◽  
Vol 129 (Suppl_1) ◽  
Author(s):  
Morteza Mahmoudi ◽  
Vahid Serpooshan ◽  
Phillip C Yang ◽  
Mahyar Heydarpour

Introduction: It is well understood that the occurrence, progress, and treatment of heart failure, which is a leading cause of death worldwide, is sex-specific. Over the past decade, the majority of efforts in myocardial regeneration have been centered on cell-based cardiac repair. A promising cell source for these efforts is patient-specific human cardiomyocytes (CMs) differentiated from human inducible pluripotent stem cells (hiPSCs). However, successful use of hiPSC-CMs faces a major limitation, the poor engraftment and electromechanical coupling of transplanted cells with the host myocardial tissue. Magnetic nanoparticles (NPs) demonstrate great potential to address this challenge for treating heart failure via cell therapies. In particular, superparamagnetic iron oxide NPs (SPIONs) have been used to label hiPSC-CMs and, with the aid of external magnetic field, improve their engraftment and electromechanical coupling in the heart tissue. However, the critical role of cell sex in the uptake and labeling efficacy of NPs has not been evaluated. Hypothesis: Significant differences in the molecular and structural (e.g., actin structures and distribution) characteristics of male and female hiPSC-CMs affect their labeling efficacy with SPIONs. Methods and Results: To test our hypothesis, we first performed RNA-Seq analysis on three male and three female (healthy) hiPSC-CM lines. The normalized outcomes were analyzed by edgeR package. We next calculated gene-expression differential between male and female CMs. The results revealed 58 genes with significant differences between the male and female cells (p-value < 0.01). The highest observed sex-specific variation in genes was related to tophit gene (MEG3: logFC = 7.32, P-value = 5.63e -06 ), which is the maternally expressed imprinted gene with a great role in cardiac angiogenesis. Among the identified genes, a number of those were related to the cellular cytoskeletal structures including actin. We probed possible structural differences between actin filaments organization and distribution of male and female hiPSC-CMs using the stochastic optical reconstruction microscopy (STORM) technique. The results demonstrated substantial differences in organization, distribution, and morphology of actin filaments between male and female CMs. Incubation of SPIONs with male and female hiPSC-CMs revealed higher uptake of NPs (~ 3 folds) in female cells as compared to the male cells. The significant differences in the uptake of SPIONs by male vs. female cells could be attributed to the distinct organization, distribution, and morphology of actin in male vs. female cells. Conclusions: Our results indicate that male and female hiPSCs-CMs respond differently to the labeling SPIONs.


2016 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Fujiko Morita ◽  
Yuji Hirai ◽  
Kiyozumi Suzuki ◽  
Yuki Uehara ◽  
Kazunori Mitsuhashi ◽  
...  

2000 ◽  
Vol 2 ◽  
pp. 94-95
Author(s):  
Claudio Ceconi ◽  
Angelo Corti ◽  
Tiziana Bachetti ◽  
Maurizio Volterrani ◽  
Cristina Opasich ◽  
...  

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Maurizio Gasparini ◽  
Frédéric Anselme ◽  
Jacques Clémenty ◽  
Massimo Santini ◽  
José Martinez-Ferrer ◽  
...  

Aim: To investigate the efficacy and safety of anti-tachycardia pacing (ATP) simultaneously delivered from right and left ventricles (BIV) vs conventional right ventricular (RV) delivery in heart failure (HF) patients treated with a biventricular ICD (CRT-D). Methods : Multicenter, prospective, randomized, controlled trial of pts implanted with a Medtronic CRT-D device. Anti-tachycardia detections were programmed: VF detection set at NID 18/24 for ≥250 bpm; FVT (via VF) with NID 18/24 between 188–250 bpm; VT detected when 20 consecutive RR intervals ≥143 bpm. Randomization was 1:1 to either BiV or RV ATP (single burst 8 pulse, 88% coupling interval ). Pts were followed for 12 months. Stored EGM, used to classify all spontaneous episodes, as well as all adverse events (including death) were adjudicated by an independent committee adjusting for pts with multiple episodes. The primary end-point (PEP) compared the efficacy of first BiV vs RV to terminate any ventricular tachyarrhythmias (VTs). The secondary composite end-point (SEP) compared adverse events (accelerations+ syncope/pre-syncope) to assess safety. Results : In total, 526 patients were enrolled and randomized (BiV = 260, RV = 266). There were no baseline differences between groups. In total, 1077 detections in 178 patients were recorded: 634 were true VTs in 119 patients (69 VF [11%] in 18 pts, 202 FVT [32%] in 49 pts, and 363 VT [57%] in 92 pts). PEP: Efficacy of first ATP was comparable between BiV (65%) and RV (68%) (p=0.58). In VT zone, RV was better (62% vs 71%., p=0.24), while in FVT zone BIV proved better (71% vs. 61%, p=0.33). RV ATP was significantly less effective in ischemic (I) pts (81% vs 59%, p=0.005). SEP: BIV ATP was ineffective 20 times and 3 accelerations occurred, whereas RV ATP failed 41 times and 14 accelerations occurred (p=0.12). Syncope/pre-syncope events never occurred for BiV ATP, while 4 times (3%) in RV ATP(p=0.3). No difference in mortality was observed. Conclusion : This trial demonstrated that ATP is also effective in CRT-D recipients. No significant differences in overall ATP efficacy were found between BIV and RV, but RV was significantly less effective in I patients; BIV was effective across different etiologies and showed a trend for superior safety profile.


EP Europace ◽  
2020 ◽  
Vol 22 (5) ◽  
pp. 777-786 ◽  
Author(s):  
Francesco Maffessanti ◽  
Tomasz Jadczyk ◽  
Radosław Kurzelowski ◽  
François Regoli ◽  
Maria Luce Caputo ◽  
...  

Abstract Aims The aim of this study was to determine the relationship between electrical and mechanical activation in heart failure (HF) patients and whether electromechanical coupling is affected by scar. Methods and results Seventy HF patients referred for cardiac resynchronization therapy or biological therapy underwent endocardial anatomo-electromechanical mapping (AEMM) and delayed-enhancement magnetic resonance (CMR) scans. Area strain and activation times were derived from AEMM data, allowing to correlate mechanical and electrical activation in time and space with unprecedented accuracy. Special attention was paid to the effect of presence of CMR-evidenced scar. Patients were divided into a scar (n = 43) and a non-scar group (n–27). Correlation between time of electrical and mechanical activation was stronger in the non-scar compared to the scar group [R = 0.84 (0.72–0.89) vs. 0.74 (0.52–0.88), respectively; P = 0.01]. The overlap between latest electrical and mechanical activation areas was larger in the absence than in presence of scar [72% (54–81) vs. 56% (36–73), respectively; P = 0.02], with smaller distance between the centroids of the two regions [10.7 (4.9–17.4) vs. 20.3 (6.9–29.4) % of left ventricular radius, P = 0.02]. Conclusion Scar decreases the association between electrical and mechanical activation, even when scar is remote from late activated regions.


Sign in / Sign up

Export Citation Format

Share Document